Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection

Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection is a paper indexed in PICO Portal from OpenAlex.

How many citations does Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection have?

Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection has 213 citations in the OpenAlex counts PICO Portal stores.

When was Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection published?

Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection has 2013 year in the PICO Portal index.

What is the open-access status of Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection?

Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection has closed oa status in the PICO Portal index.

What is the DOI of Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection?

The DOI for Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection is on the source record.

What is the PMID of Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection?

The PMID for Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection is on the source record.

What is the OpenAlex record for Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection?

The OpenAlex for Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection is on the source record.